regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention CMS, the most common co-covered peer. They are less corroborated than the beat average, carrying 3 original sources each against 3.3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Rachel O'Brien
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention CMS, the most common co-covered peer. They are less corroborated than the beat average, carrying 3 original sources each against 3.3 for the same window. Their average consequence score of 6 runs below the beat's 6.4 for that window. Rachel O'Brien appears in 1 tracked Legal story from February 27, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 47 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Rachel O'Brien. Shared-story counts are live from our verified record — not editorial picks.
Pennsylvania's Medicaid payments have undergone an unprecedented 12,000% increase over seven years, jumping from $5 million to $600 million. This exponential growth has sparked intense regulatory scrutiny and calls for advanced RegTech intervention to address potential systemic fraud.